Aamy Lifescience & Diagnostics Pvt Ltd. ( ALDPL ) founded in 2023 a very new setup with Vast experience of more than twenty years of Marketing, Sales and research experience in this area. The Company is established to manufacture In- vitro Diagnostic (IVD) products with latest techno-art procedures. ALDPL is the first and one of the biggest state of the art diagnostics manufacturing facility in Gujarat India. We aim to manufacture the world class products mainly focusing on Rapid Test Kits for Human & Veterinary, Elisa, Molecular Biology, Point of Care testing ( POCT) Liquid Clinical Chemistry.
ALDPL is one of the Biotechnology company which will be engaged in producing multiple diagnostic kits / procedures under one roof. We have one of the best, highly experienced & highly dedicated personals to produce high-quality products to serve the life on earth.
Point-of-care testing (POCT) is a powerful diagnostic tool that brings testing...
Human rapid tests are a type of diagnostic test that provide quick results, usually...
Molecular diagnostics is a revolutionary branch of medicine that delves into...
Clinical chemistry tests are more than just blood work – they're a window into...
Happy Patients
Qualified Doctors
Clinic Rooms
Local Partners

We were facing logistical challenges with our previous supplier, but ALDPL stepped in as a true partner. Their efficient communication and proactive problem-solving ensured our production stayed on track. We highly recommend them!

Our Family Doctor, a renowned infectious disease specialist, highlights ALDPL's commitment to cutting-edge technology and rigorous quality control measures in their rapid test development.They provide great service & products.

We were amazed by the speed at which ALDPL delivered our custom-designed rapid test kits. Their efficient production process and streamlined logistics allowed us to launch our new product ahead of schedule, giving us a significant market advantage.

ALDPL is at the forefront of rapid test innovation. Their commitment to research and development has led to breakthroughs in early disease detection and point-of-care testing. I'm confident their contributions will shape the future of diagnostics.

ALDPL's partnership has been instrumental in our efforts to provide accessible healthcare to underserved communities. Their affordable and reliable rapid tests have enabled us to expand our testing programs and reach more people in need.